ADA Scientific Sessions 2026 Abstract
Real-World Evidence on Efficacy and Safety of Semaglutide in Patients with Type 2 Diabetes and Advanced Chronic Kidney Disease
Study in peopleInterventions
The paper
Dubai
ADA Scientific Sessions 2026 Abstract, 5 Jun 2026
Presented at ADA Scientific Sessions 2026, late-breaking 2818-LB
